Author

Bieke Lambert

Observed names: B LAMBERT, B Lambert, B. Lambert, LAMBERT B, Lambert, Bieke

Observed institutions: Université Libre de Bruxelles, AZ Groeninge, Ghent University Hospital, Institut Jules Bordet, Erasmus Hospital, Ghent University, Hôpital Saint-André, Hôpital Pellegrin, AZ Maria Middelares, Fondazione IRCCS Istituto Nazionale dei Tumori, Université Bordeaux Segalen

ORCID: 0000-0002-5674-0222

Observed ORCID: 0000-0002-5674-0222

OpenAlex ID: A5015076780

Surveillance or Metastasis-Directed Therapy for Oligometastatic Prostate Cancer Recurrence: A Prospective, Randomized, Multicenter Phase II Trial

2017 · Piet Ost, Dries Reynders, et al. · Journal of Clinical Oncology · 1,359

Phase III Trial Comparing Protracted Intravenous Fluorouracil Infusion Alone or With Yttrium-90 Resin Microspheres Radioembolization for Liver-Limited Metastatic Colorectal Cancer Refractory to Standard Chemotherapy

2010 · Alain Hendlisz, Marc Van den Eynde, et al. · Journal of Clinical Oncology · 408

PDF

Long-Term Outcomes and Genetic Predictors of Response to Metastasis-Directed Therapy Versus Observation in Oligometastatic Prostate Cancer: Analysis of STOMP and ORIOLE Trials

2022 · Matthew P. Deek, Kim Van der Eecken, et al. · Journal of Clinical Oncology · 265

PDF

Repeated stereotactic body radiotherapy for oligometastatic prostate cancer recurrence

2014 · Karel Decaestecker, Gert De Meerleer, et al. · Radiation Oncology · 257

PDF

EANM procedure guideline for the treatment of liver cancer and liver metastases with intra-arterial radioactive compounds

2011 · Francesco Giammarile, Lisa Bodei, et al. · European Journal of Nuclear Medicine and Molecular Imaging · 233

90 Y Radioembolization versus Drug-eluting Bead Chemoembolization for Unresectable Hepatocellular Carcinoma: Results from the TRACE Phase II Randomized Controlled Trial

2022 · Elisabeth Dhondt, Bieke Lambert, et al. · Radiology · 209

PDF

Research Reporting Standards for Radioembolization of Hepatic Malignancies

2011 · Riad Salem, Robert J. Lewandowski, et al. · Journal of Vascular and Interventional Radiology · 201

PDF

Salvage Stereotactic Body Radiotherapy for Patients With Limited Prostate Cancer Metastases: Deferring Androgen Deprivation Therapy

2012 · Patrick Berkovic, Gert De Meerleer, et al. · Clinical Genitourinary Cancer · 191

Guidelines on nuclear medicine imaging in neuroblastoma

2018 · Zvi Bar-Sever, Lorenzo Biassoni, et al. · European Journal of Nuclear Medicine and Molecular Imaging · 169

Surveillance or metastasis-directed therapy for oligometastatic prostate cancer recurrence (STOMP): Five-year results of a randomized phase II trial.

2020 · Piet Ost, Dries Reynders, et al. · Journal of Clinical Oncology · 156

Prognostic factors influencing prostate cancer‐specific survival in non‐castrate patients with metastatic prostate cancer

2013 · Piet Ost, Karel Decaestecker, et al. · The Prostate · 137

Surveillance or metastasis-directed Therapy for OligoMetastatic Prostate cancer recurrence (STOMP): study protocol for a randomized phase II trial

2014 · Karel Decaestecker, Gert De Meerleer, et al. · BMC Cancer · 136

PDF

Quantitative Imaging for Targeted Radionuclide Therapy Dosimetry - Technical Review

2017 · Tiantian Li, Edwin C. I. Ao, et al. · Theranostics · 99

PDF

Validation of the mIBG skeletal SIOPEN scoring method in two independent high-risk neuroblastoma populations: the SIOPEN/HR-NBL1 and COG-A3973 trials

2017 · Ruth Ladenstein, Bieke Lambert, et al. · European Journal of Nuclear Medicine and Molecular Imaging · 92

PDF

PET with 18F-labelled choline-based tracers for tumour imaging: a review of the literature

2010 · Koen Mertens, Dominique Slaets, et al. · European Journal of Nuclear Medicine and Molecular Imaging · 92

Renal Toxicity after Radionuclide Therapy

2004 · Bieke Lambert, Markus Cybulla, et al. · Radiation Research · 92

123I-mIBG scintigraphy in neuroblastoma: development of a SIOPEN semi-quantitative reporting ,method by an international panel

2016 · V. Lewington, B. Lambert, et al. · European Journal of Nuclear Medicine and Molecular Imaging · 87

PDF

Validation of Postinduction Curie Scores in High-Risk Neuroblastoma: A Children’s Oncology Group and SIOPEN Group Report on SIOPEN/HR-NBL1

2017 · Gregory A. Yanik, Marguerite T. Parisi, et al. · Journal of Nuclear Medicine · 83

PDF

Bone marrow dosimetry and safety of high 131I activities given after recombinant human thyroid-stimulating hormone to treat metastatic differentiated thyroid cancer.

2004 · Bart de Keizer, Anne Hoekstra, et al. · PubMed · 75

Clinical applications of 188Re-labelled radiopharmaceuticals for radionuclide therapy

2006 · Bieke Lambert, John M.H. de Klerk · Nuclear Medicine Communications · 65

188Re-HDD/lipiodol therapy for hepatocellular carcinoma: a phase I clinical trial.

2005 · Bieke Lambert, Klaus Bacher, et al. · PubMed · 65

Prevalence and prognosis of low‐volume, oligorecurrent, hormone‐sensitive prostate cancer amenable to lesion ablative therapy

2017 · Aurélie De Bruycker, Bieke Lambert, et al. · British Journal of Urology · 63

Nodal Oligorecurrent Prostate Cancer: Anatomic Pattern of Possible Treatment Failure in Relation to Elective Surgical and Radiotherapy Treatment Templates

2018 · Aurélie De Bruycker, Elise De Bleser, et al. · European Urology · 59

Low levels of serum thyroglobulin after withdrawal of thyroid suppression therapy in the follow up of differentiated thyroid carcinoma

1990 · A. J. Brendel, B. Lambert, et al. · European Journal of Nuclear Medicine and Molecular Imaging · 56

Treatment of hepatocellular carcinoma by means of radiopharmaceuticals

2005 · Bieke Lambert, Christophe Van de Wiele · European Journal of Nuclear Medicine and Molecular Imaging · 51

Works count: 130

Citation count: 5,489

H-index: 30

I10-index: 56